Pradeep Shrestha

6PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 20, 2026
Exercise modulates microbial metabolites and induces stromal remodeling in pancreatic cancer.

|Oct 13, 2025
Inhibition of osteosarcoma lung metastases by β-glucan and CD40 agonist is mediated by activation of macrophages and NK cells.

Pradeep Shrestha, Rejeena Shrestha, Eugenie S Kleinerman

|Feb 13, 2023
Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease.

Pradeep Shrestha, Ali Turan, Lalit Batra

|Dec 11, 2022
The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity.

Anchit Bhagat, Pradeep Shrestha, Eugenie S Kleinerman

|Dec 19, 2019
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.

Kyle B Woodward, Hong Zhao, Pradeep Shrestha

|Feb 17, 2019
A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer Cells.

Hampartsoum B Barsoumian, Lalit Batra, Pradeep Shrestha

Pageof 1

Frequent Collaborators

3 joint publications

Haval Shirwan

2 joint publications

Lalit Batra

2 joint publications

Esma S Yolcu

1 joint publications

Jorge G Gomez-Gutierrez